Tag: first-in-human cancer drug development

Conformation-Selective PI3Kδ Inhibitor Roginolisib Shows Safety and Survival Signals in First-in-Human Cancer Trial

by Nathaniel Bowman

October 11, 2026

A first-in-human trial shows that the conformation-selective PI3Kδ inhibitor roginolisib is well tolerated in advanced cancers and is associated with ...

Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!

Tag: first-in-human cancer drug development

Conformation-Selective PI3Kδ Inhibitor Roginolisib Shows Safety and Survival Signals in First-in-Human Cancer Trial

Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept

Bee body mass, pathogens and local climate influence heat tolerance

Researchers record first-ever images and data of a shark experiencing a boat strike

Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function

RECENT NEWS

Categories

Subscribe to Blog via Email

Welcome Back!

Retrieve your password